Whole exome sequencing of Rb1 and Trp53 deficient (RP) SCLC mouse model
收藏官方服务：
资源简介：
Whole exome sequencing of Rb1 and Trp53 deficient (RP) SCLC mouse model
应用场景：
创建时间：
2019-07-09
相关数据集
Isolation of Circulating Tumor Cells from Small Cell Lung Cancer patients using CD56+ as a marker. Isolation of Circulating Tumor Cells from Small Cell Lung Cancer patients using CD56+ as a marker
We have isolated Circulating Tumor Cells from four Small Cell Lung Cancer Patients at diagnosis and relapse using a two-step method developed in the laboratory. Subsequently, Whole-Exome sequencing wa
NIAID Data Ecosystem70
Table S4 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
Fusion analysis results calculated with STARfusion and summary of RLF exon1 and exon2 expression for the CCLE cohort. Table summarizes the RLF-MYCL expression qPCR results.
NIAID Data Ecosystem30
TTF-1/NKX2-1 and ASCL1 binding regions in a small cell lung carcinoma cell line, NCI-H209
Although Thyroid transcription factor-1 (TTF-1, encoded by NKX2-1 gene) is highly expressed in small cell lung carcinoma (SCLC) and lung adenocarcinoma (LADC), difference in the functional roles of TT
NIAID Data Ecosystem10
Table S1 from Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes
Expression and copy-number status of recurrently highly amplified genes in patient and cell line samples. The tables summarize copy-number signal and AmpliconArchitect curation, expression of key gene
NIAID Data Ecosystem30
DataSheet_8_Whole-Exome Sequencing Uncovers Specific Genetic Variation Difference Based on Different Modes of Drug Resistance in Small Cell Lung Cancer.pdf
The poor survival rate of small cell lung cancer (SCLC) is mainly related to the condition that patients with SCLC often have good responses to first-line chemotherapy initially, but later on, most of
NIAID Data Ecosystem20
